43 completed, 24 recruiting, 15 unknown, 12 active not recruiting. 57 Not applicable, 22 Phase 2, 6 Phase 1, 1 Phase 3, 1 Phase 4.
Follow Institute of Oncology Ljubljana: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy Structured Resistance Exercise, Individualized Nutritional Support - Melanoma | Not applicable | Not yet recruiting | Institute of Oncology Ljubljana | 40 | 2026-12-01 | 2026-10-07 |
| Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity PICC Line Placement, Vessels; Anomaly | Not yet recruiting | University Medical Centre Ljubljana | 80 | 2026-11-01 | 2026-08-27 | |
| ctDNA and TEP Levels in Colon Cancer Additional Peripheral Venous Blood Sampling for ctDNA and TEP Biomarker Analysis - Colon Cancer | Not applicable | Not yet recruiting | Institute of Oncology Ljubljana | 80 | 2026-11-01 | 2026-10-07 |
| Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST) Bleomycin Sulfate - Vascular Malformations | Phase 2 | Recruiting | Institute of Oncology Ljubljana | 140 | 2026-09-10 | 2026-10-09 |
| Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer Adherence package consisting of additional education and adherence reminders - Breast Cancer, Adherence, Medication | Phase 4 | Not yet recruiting | Institute of Oncology Ljubljana | 90 | 2026-09-01 | 2026-06-05 |
| Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers Prophylactic External Beam Radiotherapy, Standard of Care - Bone Metastases, Metastatic Solid Tumor | Phase 2 | Recruiting | Institute of Oncology Ljubljana | 90 | 2026-06-02 | 2026-10-09 |
| ProspectiveFemaleAYA - Late Effects of Cancer Therapies on Gonadal Function, Fertility, Efficiency of Fertility Preservation Procedures and Pregnancy Outcomes Cancer, Cancer in Pregnancy | Not yet recruiting | Karolinska Institutet | 3000 | 2026-06-01 | 2026-06-03 | |
| Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study Lidocaine, Placebo - Colon Cancer | Phase 2 | Recruiting | Institute of Oncology Ljubljana | 100 | 2026-02-03 | 2026-02-05 |
| Resting Energy Expenditure by Gastrointestinal Functional Status Protocol-Defined Metabolic and Body Composition Assessment - Intestinal Failure, Short Bowel Syndrome | Not applicable | Recruiting | Institute of Oncology Ljubljana | 92 | 2025-10-01 | 2026-07-20 |
| Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study) Lidocaine, Dexamethasone, Placebo - Colon Cancer, Colorectal Cancer | Phase 2 | Recruiting | Institute of Oncology Ljubljana | 100 | 2025-09-01 | 2026-03-06 |
| Pilot Study of the Expansion of the DORA Breast Cancer Screening Programme Screening Mammography - Breast Cancer Screening | Not applicable | Enrolling by invitation | Institute of Oncology Ljubljana | 2150 | 2025-09-01 | 2026-09-23 |
| Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS) Primary Tumor mRNA Expression Profiling (NGS), Serum Chemokine Quantification (ELISA) - Breast Cancer, Central Nervous System Metastases | Not applicable | Active not recruiting | Institute of Oncology Ljubljana | 22 | 2025-07-07 | 2026-03-03 |
| Use of AlignRT System During Stereotactic Radiosurgery Manual Patient Positioning, AlignRT-Guided Patient Positioning - Brain Metastases | Not applicable | Completed | Institute of Oncology Ljubljana | 20 | 2025-04-01 | 2026-07-21 |
| Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme Comprehensive Clinical and Genetic Breast Cancer Risk Assessment - Breast Cancer, Breast Cancer Risk | Not applicable | Recruiting | Institute of Oncology Ljubljana | 291 | 2025-03-10 | 2026-07-29 |
| Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer Early Breast Cancer, Hormone Receptor Positive Tumor | Recruiting | Institute of Oncology Ljubljana | 319 | 2025-01-05 | 2026-03-06 | |
| Pilot Study of Individualized Treatment for Genitourinary Syndrome of Menopause in Women After Cancer Treatment Non-ablative vaginal Er:YAG laser therapy, Standard care - Genitourinary Syndrome of Menopause (GSM), Vaginal Dryness | Not applicable | Active not recruiting | Institute of Oncology Ljubljana | 65 | 2024-10-15 | 2026-02-19 |
| Gene Methylation for Diagnosis of Breast Lesions Gene Methylation Analysis of BRCA1, RASSF1A and PTEN - Breast Lesions of Uncertain Malignant Potential, PTEN | Not applicable | Completed | Institute of Oncology Ljubljana | 401 | 2024-09-01 | 2026-02-24 |
| BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential MS-MLPA Methylation Analysis - Breast Cancer, Breast Lesions of Uncertain Malignant Potential (B3 Lesions) | Not applicable | Completed | Institute of Oncology Ljubljana | 301 | 2024-09-01 | 2026-02-25 |
| IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma Pembrolizumab, Nivolumab, Ipilimumab/Nivolumab - Metastatic Melanoma, Malignant Melanoma | Not applicable | Completed | Institute of Oncology Ljubljana | 132 | 2024-03-31 | 2026-03-02 |
| Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA Liquid biopsy - Breast Cancer | Not applicable | Recruiting | Institute of Oncology Ljubljana | 130 | 2024-02-07 | 2026-02-18 |
Showing 20 of 101. Sign in to see all of them.
Breast Neoplasms (15) · Melanoma (11) · Rectal Neoplasms (10) · Colonic Neoplasms (5) · Head and Neck Neoplasms (5) · Colorectal Neoplasms (4) · Skin Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (3) · Sarcopenia (3) · Brain Neoplasms (2) · Carcinoma, Renal Cell (2) · Endocrine System Diseases (2) · Esophageal Neoplasms (2) · Intestinal Failure (2) · Liver Neoplasms (2)
Electrochemotherapy (8) · Capecitabine (5) · Cisplatin (4) · Bleomycin (3) · Cetuximab (3) · Immune Checkpoint Inhibitors (3) · Blood Specimen Collection (2) · Ipilimumab (2) · Lidocaine (2) · Liquid Biopsy (2) · Nivolumab (2) · Radiosurgery (2) · Radiotherapy (2) · Standard of Care (2) · pembrolizumab (2)
Slovenia (96) · Austria (2) · Ireland (1) · Israel (1) · Italy (1) · Norway (1) · Sweden (1)
Gregor Sersa, PhD (3) · Blaz Trotovsek, MD, PhD (2) · Vaneja Velenik, PhD, MD (2) · Barbro K Linderholm, MD, PhD (1) · Borut Stabuc, MD, PhD (1) · Bostjan Markelc, PhD (1) · Branko Zakotnik, Prof. (1) · David Badovinac, MD (1) · Dimitrij Kuhelj, MD, PhD (1) · Dragoje Stanisavljevic, MD (1) · Eldar Gadzijev, MD, PhD (1) · Erika Matos, PhD (1) · Gaber Plavc, MD (1) · Gregor Sersa, PhD (Biol.) (1)
PMID 17042060, PMID 20920276, PMID 21895032, PMID 25063039, PMID 26834518, PMID 27776943, PMID 33794207, PMID 34534974, PMID 34958422, PMID 36599120, PMID 37748261, PMID 40272186, PMID 42793498
2025 (3)